We are live on
!
Find out more
TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$4.08B
1-Year Est. Return
58.77%
This Fund
S&P 500
This Quarter
Est. Return
-0.27%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.92B
AUM Growth
+$75.1M
(+2%)
Cap. Flow
+$135M
Cap. Flow
% of AUM
3.46%
Top 10 Holdings %
Top 10 Hldgs %
32.39%
Holding
6,700
New
1,026
Increased
2,252
Reduced
2,490
Closed
691
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$342M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$83.1M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$43.8M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$40.2M |
| 5 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$26.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$19.9M |
| 2 |
iShares Semiconductor ETF
SOXX
|
+$19M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$18.2M |
| 4 |
Salesforce
CRM
|
+$16.1M |
| 5 |
Tesla
TSLA
|
+$14.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.5% |
| 2 | Consumer Discretionary | 8.04% |
| 3 | Healthcare | 7.14% |
| 4 | Communication Services | 6.4% |
| 5 | Financials | 6.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4526
Cibus
CBUS
$143M
| $8K | ﹤0.01% |
42
-87
| -67% | -$16.8K |
|
4527
Deutsche Bank
DB
$72.1B
| $8K | ﹤0.01% |
596
-939
| -61% | -$11.8K |
|
4528
Ginkgo Bioworks
DNA
$490M
| $8K | ﹤0.01% |
+18
| New | +$8.76K |
|
4529
DarioHealth
DRIO
$72.1M
| $8K | ﹤0.01% |
28
-108
| -79% | -$31.2K |
|
4530
State Street SPDR S&P International Dividend ETF
DWX
$529M
| $8K | ﹤0.01% |
200
| – | – |
|
4531
E-Power Inc
EPOW
$21.2M
| $8K | ﹤0.01% |
3,405
+1,496
| +78% | +$3.99K |
|
|
ETNB
4532
DELISTED
89bio
ETNB
| $8K | ﹤0.01% |
416
-7,776
| -95% | -$142K |
|
4533
Edgewise Therapeutics
EWTX
$4.82B
| $8K | ﹤0.01% |
471
+177
| +60% | +$3.2K |
|
4534
First Trust Natural Gas ETF
FCG
$650M
| $8K | ﹤0.01% |
480
+180
| +60% | +$2.62K |
|
|
FORA
4535
DELISTED
Forian
FORA
| $8K | ﹤0.01% |
786
-313
| -28% | -$3.48K |
|
4536
HireQuest
HQI
$231M
| $8K | ﹤0.01% |
421
-412
| -49% | -$7.91K |
|
4537
IES Holdings
IESC
$16B
| $8K | ﹤0.01% |
186
-1,960
| -91% | -$95.3K |
|
4538
iShares Core MSCI Europe ETF
IEUR
$9.16B
| $8K | ﹤0.01% |
146
-167
| -53% | -$9.74K |
|
4539
Immatics
IMTX
$1.35B
| $8K | ﹤0.01% |
651
-213
| -25% | -$2.71K |
|
4540
Intelligent Bio Solutions
INBS
$4.95M
| $8K | ﹤0.01% |
1
| – | – |
|
|
IOR
4541
Income Opportunity Realty Investors
IOR
| $8K | ﹤0.01% |
753
+532
| +241% | +$6.57K |
|
4542
iSpecimen
ISPC
$3.2M
| $8K | ﹤0.01% |
+2
| New | +$9.71K |
|
4543
Coffee Holding Co
JVA
$20M
| $8K | ﹤0.01% |
1,669
+417
| +33% | +$2.13K |
|
4544
Korro Bio
KRRO
$200M
| $8K | ﹤0.01% |
21
-25
| -54% | -$9.84K |
|
4545
Karat Packaging
KRT
$989M
| $8K | ﹤0.01% |
370
+322
| +671% | +$7.25K |
|
4546
Lifetime Brands
LCUT
$222M
| $8K | ﹤0.01% |
428
-5,249
| -92% | -$87.8K |
|
4547
Lipocine
LPCN
$17.4M
| $8K | ﹤0.01% |
+445
| New | +$9.82K |
|
4548
Monarch Casino & Resort
MCRI
$2.22B
| $8K | ﹤0.01% |
113
-541
| -83% | -$35K |
|
|
KG
4549
Kestrel Group
KG
$68.8M
| $8K | ﹤0.01% |
128
-412
| -76% | -$27K |
|
4550
Moving iMage Technologies
MITQ
$5.49M
| $8K | ﹤0.01% |
+2,977
| New | +$12.6K |
|
Similar funds
CA
BHC
ICP
AP
BWA
JSW
SP
GCM
Tower Research Capital (TRC)'s Q3 2021 Portfolio in Review
As of Q3 2021, Tower Research Capital (TRC) held 6,700 positions worth $3.92B, up 2% from $3.84B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Tower Research Capital (TRC) deployed $135M of net new capital in Q3 2021, opening 1,026 new positions and adding to 2,252 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was UnitedHealth, an estimated $19.9M trimmed.
- Tower Research Capital (TRC)'s largest Q3 2021 buy was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.
- Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $342M increase.
- Tower Research Capital (TRC)'s biggest Q3 2021 reduction was UnitedHealth, cutting an estimated $19.9M.
- Tower Research Capital (TRC) fully exited iShares Semiconductor ETF in Q3 2021, selling an estimated $19M.
- Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.92B portfolio in Q3 2021.
- Tower Research Capital (TRC) opened 1,026 new positions and closed 691 in Q3 2021.
- Tower Research Capital (TRC)'s portfolio value rose 2% quarter-over-quarter to $3.92B.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.